On-Demand: Managing Type I and Type II Diabetes
General/Consultant (3 hrs. CPE)

Home On-Demand: Managing Type I and Type II Diabetes
General/Consultant (3 hrs. CPE)

On-Demand: Managing Type I and Type II Diabetes
General/Consultant (3 hrs. CPE)

$75.00

ACCREDITATION

iCARE Pharmacy Services, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is an ACPE application-based* and knowledge-based activity. Participants may receive up to 3 hours of CPE credit by attending sessions and successfully completing the continuing pharmacy education (CPE) activity evaluation.

iCARE Pharmacy Services, Inc. is approved by the Florida Board of Pharmacy as a provider of continuing pharmacy education.

DISCLOSURES

Speakers have no relevant conflict of interests nor financial relationships.  All persons in a position to control the content of this activity have declared that no conflict of interest exists for this activity.

TARGET AUDIENCE

Pharmacists and Pharmacy Technicians of all practice backgrounds.

CANCELLATION POLICY
Participants must submit cancellations in writing. Participants will receive a credit for a future CPE program.

 

Add to Wishlist
Categories: , Tag:

Description

On-Demand: Type I and Type II Diabetes

(These courses are included in the On-Demand: Managing Metabolic Disorders.)

Beyond Insulin: Advancements in Type 1 Diabetes Care                                  

Jasmine B. R. Cutler, Pharm.D., CPh, Assistant Professor, Dept of Pharmacotherapeutics and Clinical Research, USF Health Taneja College of Pharmacy, University of South Florida

Upon completion of this activity, pharmacists will be able to: Discuss the pathophysiology, clinical presentation, and risk factors of diabetes; Explain the differences between Type 1 and Type 2 diabetes; Discuss available treatment options for Type 1 diabetes; Demonstrate proper insulin administration; Discuss blood glucose monitoring and management of hypoglycemia and hyperglycemia; Introduce emerging therapies and technologies used in the treatment of diabetes, specifically Type 1 diabetes; Discuss the financial implications of Type 1 diabetes and available resources to address patient concerns and questions; Highlight lifestyle management of Type 1 diabetes; Apply learned concepts about Type 1 diabetes to a patient case.

UAN: 0675-0000-24-021-H01-P*

 

A New Era in the Management of Type 2 Diabetes              

Marile Santamarina, PharmD, CPh, CDE, CPT, Sr. Medical Science Liaison, Immunology, Fresenius Kabi USA

Upon completion of this activity, pharmacists will be able to: Provide an overview of complex pathophysiology of Type 2 Diabetes (T2D); Review change progression in the American Diabetes Association Clinical Practice Guidelines from 2018 through 2024; Discuss the clinical positioning of newer drug classes in the management of type 2 diabetes; Recommendation clinical decisions using patient practice cases.

UAN: 0675-0000-24-023-H01-P

 

 

Related products